Stay updated on Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Removed the primary disease term 'Head and neck squamous cell carcinoma' and the related topic 'MedlinePlus Genetics' from the page, while updating the revision note from v3.3.1 to v3.3.2.
    Difference
    0.2%
    Check dated 2025-12-01T12:46:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added related topics including Head and neck squamous cell carcinoma and MedlinePlus Genetics, and updated the PubMed publication note by removing older phrasing.
    Difference
    0.2%
    Check dated 2025-11-24T12:21:19.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page removed the government operating status notice and deleted the 'Head and neck squamous cell carcinoma' topic and the 'MedlinePlus Genetics' related topics section.
    Difference
    0.5%
    Check dated 2025-11-17T06:23:20.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added related topic links for 'Head and neck squamous cell carcinoma' and 'MedlinePlus Genetics' to the page.
    Difference
    0.1%
    Check dated 2025-11-10T03:28:43.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    No substantial modifications detected in the study details page; the layout and key data appear the same across screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T01:00:17.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added new MedlinePlus Genetics topic: Head and neck squamous cell carcinoma, expanding the page’s coverage of genetic information on a high-interest medical condition.
    Difference
    0.5%
    Check dated 2025-10-19T16:24:12.000Z thumbnail image

Stay in the know with updates to Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelimumab in Head and Neck Cancer Clinical Trial page.